Abstract

Background: Recent studies have suggested an increased risk of AMI following daylight saving time (DST) transitions in cohorts of American and European patients. We aim to validate this finding in a Canadian population. Methods: We performed a retrospective cohort study of patients admitted to the Hôpital du Sacré-Coeur de Montréal, with a diagnosis of AMI requiring a PCI. Patients aged ≥18 years hospitalized between 2018 and 2022 were included. The primary endpoint was the incidence of AMI two weeks following DST transitions. The secondary endpoint was infarct size by biomarker assessment and LVEF. Results: 1142 charts were reviewed with 775 patients meeting the inclusion criteria (244 in the study group and 531 in the control group). Baseline clinical characteristics were comparable between both groups. (Table 1) The rate of AMI per day following DST transitions was 1.74 compared to 1.90 during control periods. DST was not associated with an increase in AMI (IRR = 0.92, 95% CI 0.79 - 1.07, p = 0.295). (Table 2) During the spring shift, the IRR was 0.83, p = 0.106, and during the autumn shift, the IRR was 1.01, p = 0.933. The rate of AMI was higher on the first day following DST, but it did not reach statistical significance (rate of AMI per day = 2.00; IRR = 1.05; p = 0.845). The transition to DST was not associated with a larger infarct size by CK-MB assessment, but LVEF was significantly slightly higher following DST transitions (LVEF 50 ± 11 % vs 48 ± 10 %, p = 0.038). Conclusion: In this cohort of Canadian patients, there was no significant association between DST transitions and the incidence of AMI. LVEF was higher following DST transitions, but infarct size was similar between study and control groups.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call